Carmichael Hill & Associates’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $31 | Hold |
2
| – | – | ﹤0.01% | 662 |
|
|
2024
Q2 | $154 | Hold |
2
| – | – | ﹤0.01% | 662 |
|
|
2024
Q1 | $125 | Hold |
2
| – | – | ﹤0.01% | 663 |
|
|
2023
Q4 | $154 | Hold |
2
| – | – | ﹤0.01% | 669 |
|
|
2023
Q3 | $82 | Hold |
2
| – | – | ﹤0.01% | 670 |
|
|
2023
Q2 | $122 | Hold |
2
| – | – | ﹤0.01% | 672 |
|
|
2023
Q1 | $137 | Hold |
2
| – | – | ﹤0.01% | 669 |
|
|
2022
Q4 | $58 | Hold |
2
| – | – | ﹤0.01% | 661 |
|
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 786 |
|
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 782 |
|
|
2022
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 741 |
|
|
2021
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 739 |
|